Lipella Pharmaceuticals (LIPO) News Today → Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad) Free LIPO Stock Alerts $0.71 0.00 (0.00%) (As of 04/19/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineLipella Pharmaceuticals Expands its Advisory Board to Include Oncology Expertisefinance.yahoo.com - April 17 at 10:15 AMLipella Pharmaceuticals Expands its Advisory Board to Include Oncology Expertiseglobenewswire.com - April 17 at 8:00 AMLipella Pharmaceuticals Inc. (NASDAQ:LIPO) Short Interest Updateamericanbankingnews.com - April 15 at 5:58 AMLipella Pharmaceuticals (NASDAQ:LIPO) Now Covered by Analysts at Maxim Groupamericanbankingnews.com - April 10 at 3:54 AMLipella Pharmaceuticals to Publish Abstract Detailing Compelling Preclinical Support for New Product Candidate at ASCO 2024globenewswire.com - April 5 at 8:00 AMLipella Pharmaceuticals Announces Type C Meeting For LP-10 - Quick Factsmarkets.businessinsider.com - April 3 at 10:58 AMLipella Pharmaceuticals Announces FDA Type C Meeting for LP-10 for Hemorrhagic Cystitisglobenewswire.com - April 3 at 8:00 AMLipella Pharmaceuticals Inc. (NASDAQ:LIPO) Insider Jonathan H. Kaufman Purchases 30,000 Sharesinsidertrades.com - March 20 at 7:32 AMPRISM MarketView Spotlights Lipella Pharmaceuticals as it Seizes Opportunities in Rare Diseasefinance.yahoo.com - March 7 at 4:25 PMLipella Pharma's IND Application For LP-410 Gets FDA's Approvalmarkets.businessinsider.com - March 5 at 12:54 PMLipella Pharmaceuticals Inc Ordinary Shares LIPOmorningstar.com - March 3 at 5:42 PMLipella Pharmaceuticals Full Year 2023 Earnings: US$0.77 loss per share (vs US$0.64 loss in FY 2022)finance.yahoo.com - March 1 at 8:43 AMLipella Pharmaceuticals to Present at PropThink Digital Investor Conferencefinance.yahoo.com - February 20 at 12:33 PMLipella Pharmaceuticals to Present at PropThink Digital Investor Conferenceglobenewswire.com - February 20 at 8:00 AMLipella Pharmaceuticals Inc. (LIPO)finance.yahoo.com - February 9 at 2:25 PMLipella Pharmaceuticals Inc.: Lipella Pharmaceuticals Marks Successful First Year with Strategic Progress and Key Milestones Accomplishedfinanznachrichten.de - December 20 at 3:44 PMLipella Pharmaceuticals Marks Successful First Year with Strategic Progress and Key Milestones Accomplishedfinance.yahoo.com - December 20 at 10:44 AMLipella Pharmaceuticals Inc Ordinary Sharesmorningstar.com - December 9 at 11:35 PMLipella Pharma: FDA Grants Orphan Designation For LP-310 To Treat Oral Graft-versus-Host Diseasemarkets.businessinsider.com - November 10 at 8:42 AMFDA Grants Orphan Designation for Lipella's LP-310 Drug Candidate for Oral Graft-versus-Host Diseasefinance.yahoo.com - November 10 at 8:42 AMLipella Pharmaceuticals Announces Closing of $2 Million Private Placement Priced At-The-Market Under Nasdaq Rulesfinance.yahoo.com - October 25 at 7:40 PMLipella Pharmaceuticals Announces $2 Million Private Placement Priced At-The-Market Under Nasdaq Rulesfinance.yahoo.com - October 24 at 8:28 AMLipella Pharmaceuticals to Present at the Fall Foliage MicroCap Rodeo Conferencefinance.yahoo.com - October 23 at 9:26 AMLipella Pharmaceuticals stock more than doubles in 3 days as FDA approves IND for OLP treatmentmsn.com - October 22 at 12:13 AMWhat's Going On With Lipella Pharmaceuticals Stock?benzinga.com - October 20 at 6:52 PMInvestors Remain Cautious Over Fed Moves, Setting Wall Street Up for Lower Openmsn.com - October 20 at 1:52 PMGold Rises Over 1%; Schlumberger Shares Fall After Q3 Resultsbenzinga.com - October 20 at 1:52 PMLipella Pharmaceuticals Shares Soar on FDA Approvalmarketwatch.com - October 20 at 8:51 AMLipella Pharmaceuticals Announces FDA Clearance of IND for LP-310 for Oral Lichen Planusfinance.yahoo.com - October 20 at 8:51 AMU.S. shares higher at close of trade; Dow Jones Industrial Average up 0.39%msn.com - October 4 at 7:02 PMU.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.39%msn.com - October 4 at 7:02 PMLipella Pharmaceuticals' Phase 2a Clinical Study Results Published in the Journal of Urology and Nephrologyfinance.yahoo.com - September 21 at 1:03 PMLipella Pharmaceuticals Inc (LIPO)investing.com - September 7 at 7:10 PMLipella Pharmaceuticals: Addressing Significant Unmet Need for Cancer Survivors, Delivering Long Term Value for Shareholdersfinance.yahoo.com - June 13 at 8:52 AMLipella Pharmaceuticals Inc.: Lipella Pharmaceuticals Reports First Quarter 2023 Financial Results and Corporate Updatefinanznachrichten.de - May 15 at 4:33 PMLipella reports Q1 resultsmsn.com - May 15 at 4:33 PMLipella Pharmaceuticals Reports First Quarter 2023 Financial Results and Corporate Updatefinance.yahoo.com - May 15 at 9:46 AMLipella Pharmaceuticals First Quarter 2023 Earnings: US$0.19 loss per share (vs US$0.19 loss in 1Q 2022)finance.yahoo.com - May 14 at 9:22 AMLipella Pharmaceuticals Delivers Late-Breaking Presentation at the American Urological Association Annual Meetingfinance.yahoo.com - May 1 at 9:43 AMLipella Pharmaceuticals Enters Manufacturing Collaboration Agreement with Cook MyoSitefinance.yahoo.com - April 17 at 1:15 PMLipella Pharmaceuticals Doses First Patient in Human Study of Innovative Contrast Agentfinance.yahoo.com - April 5 at 9:28 AMLipella Pharmaceuticals Inc.: Lipella Provides Business Update and Reports 2022 Financial Resultsfinanznachrichten.de - March 31 at 9:20 AMLipella Provides Business Update and Reports 2022 Financial Resultsfinance.yahoo.com - March 31 at 9:20 AMLipella Pharmaceuticals Successfully Completes Phase 2a Clinical Trial; Announces Late-Breaking Presentation at the Annual Meeting of the American Urological Associationfinance.yahoo.com - March 16 at 10:28 AMLipella Pharmaceuticals Announces Creation of Oral Health Scientific Advisory Boardfinance.yahoo.com - March 1 at 10:57 AMThe truth about liposuctiondailymail.co.uk - February 21 at 8:58 AMLipella Announces Closing of Initial Public Offering for Gross Proceeds of $7 Millionfinance.yahoo.com - February 21 at 8:58 AMLipella Pharmaceuticals to Present at January 2023 Biotech Showcase in San Franciscofinance.yahoo.com - February 21 at 8:58 AMLipella Pharmaceuticals Announces Successful Top Line Results of Phase 2A Clinical Trial of LP-10finance.yahoo.com - February 21 at 8:58 AMmarketbeat.com - January 11 at 9:53 AM Get Lipella Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for LIPO and its competitors with MarketBeat's FREE daily newsletter. Email Address Tiny Biotech Stock Wins $75 Billion Patent (Ad)A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda. Find out more here >>> LIPO Media Mentions By Week LIPO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LIPO News Sentiment▼0.320.52▲Average Medical News Sentiment LIPO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LIPO Articles This Week▼30▲LIPO Articles Average Week Get Lipella Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for LIPO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: EVOK News Today KA News Today BPTS News Today SNGX News Today THAR News Today VRPX News Today CING News Today SNPX News Today LMDX News Today ARTL News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LIPO) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIHe Is Giving Away BitcoinCrypto Swap ProfitsSHOCKING Crypto Leak…Crypto 101 MediaThe #1 Crypto for 2024InvestorPlaceHow Biden has already won 2024Porter & CompanyUrgent alert: open this for a huge profit potentialTimothy Sykes Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lipella Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.